Adrenomedullin disrupts insulin signaling in blood vessels, leading to systemic insulin resistance in obesity-associated type 2 diabetes.

The hormone adrenomedullin disrupts insulin signaling in blood vessel cells, contributing to systemic insulin resistance in obesity-associated type 2 ...

The hormone adrenomedullin disrupts insulin signaling in blood vessel cells, contributing to systemic insulin resistance in obesity-associated type 2 diabetes, according to a new study.

Scientists have discovered that the peptide hormone adrenomedullin plays a pivotal role in obesity-related type 2 diabetes, ...

A research team revealed that insulin-like growth factor-binding protein 6 (IGFBP6) serves as a potential therapeutic target ...

A groundbreaking stem cell therapy offers new hope for type 1 diabetes, with early results showing potential for insulin ...

The hormone triggers insulin resistance in blood vessel endothelium in obesityA large proportion of the approximately six ...

A research team revealed that insulin-like growth factor-binding protein 6 (IGFBP6) serves as a potential therapeutic target for suppressing ... role in regulating cell cycle, proliferation ...

Novel approach designed to offer a more personalized and effective treatment option for patients suffering from diabetes and ...

Regular exercise can improve brain function and “ward off dementia”, new research has indicated. Scientists from Rutgers University-New Brunswick have found that exercise activates the development of ...

One recent analysis found that, over the course of three years, people taking semaglutide (the compound in Ozempic and the ...